NFKB1 and colitis: In a recent study, Han et al. demonstrated that n-3 PUFAs prevent colitis-associated carcinogenesis through repressing NF-kB and inhibiting COX-2 production and by blocking dissociation of beta-catenin complex and inducing 15-prostaglandin dehydrogenase activity [35].